comparemela.com

Page 8 - Pharmaceutical Holdings News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rising Incidence of Polycystic Ovary Syndrome among Women Drives the U S Digital Ovulation Test Kits Market Demand: Future Market Insights Study

(0) DUBAI, UAE, June 9, 2021 /PRNewswire/ The U.S. digital ovulation test kit market grew at about 4% CAGR until 2020, according to a study by Future Market Insights (FMI). The U.S. digital ovulation test kit market is expected to reach US$ 95.1 Mn by 2031, expanding at a CAGR of 9.6% for 2021 - 2031. The demand for digital ovulation test kits will accelerate in response to the increase in working women population and rising need of self-sustained digital ovulation test kits. As per data from Centers for Disease Control and Prevention (CDC), around 6% of married women in the U.S. aged 15-44 years were unable to conceive in 2019.

TNXP: Interim Analysis for Phase 3 RALLY Trial in 3Q21; Topline Results in 1Q22…

By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonix Pharmaceutical Holdings Corp. (NASDAQ:TNXP) has undergone a transformation over the past year as it has built up a robust pipeline of clinical stage assets focused on the treatment of central nervous system (CNS) and immunological diseases. In addition, the company’s balance sheet has never been stronger. As of March 31, 2021, Tonix had approximately $164.2.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.